Detalhe da pesquisa
1.
Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice.
Mol Ther
; 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715364
2.
BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study.
Sci Rep
; 13(1): 17337, 2023 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37833554
3.
Potent pan huACE2-dependent sarbecovirus neutralizing monoclonal antibodies isolated from a BNT162b2-vaccinated SARS survivor.
Sci Adv
; 9(30): eade3470, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37494438
4.
Priming conditions shape breadth of neutralizing antibody responses to sarbecoviruses.
Nat Commun
; 13(1): 6285, 2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36271047
5.
Differential escape of neutralizing antibodies by SARS-CoV-2 Omicron and pre-emergent sarbecoviruses.
Res Sq
; 2022 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35233568
6.
SARS-CoV-2 Omicron variant emerged under immune selection.
Nat Microbiol
; 7(11): 1756-1761, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195753
7.
Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5.
Lancet Microbe
; 3(12): e898, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35963276